XDx Inks Agreement with Highmark BCBS; Florida Medicaid Begins Covering AlloMap | GenomeWeb

NEW YORK (GenomeWeb News) – XDx announced it has reached an agreement with Highmark Blue Cross Blue Shield to cover XDx's AlloMap test.

Separately, the Brisbane, Calif.-based company also said that Florida Medicaid has issued a positive coverage decision for the gene expression test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.